Press-release for stocks related to covid-19

| -71.98% | O: -0.86% H: 0.65% C: -1.2%
covid-19 vaccine mrna collaboration study

GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidate
Published: 2023-04-06 (Crawled : 14:20) - globenewswire.com
GOVX | $1.54 1.27% 35K

| 115.38% | O: -0.7% H: 4.23% C: 1.69%
covid-19 candidate vaccine presentation trial

GeoVax and EmVenio Announce Collaboration to Expand Phase 2 COVID-19 Booster Vaccine Clinical Trial
Published: 2023-02-15 (Crawled : 14:20) - globenewswire.com
GOVX | $1.54 1.27% 35K

| 71.11% | O: -1.11% H: 4.38% C: -1.12%
covid-19 collaboration vaccine trial phase 2

Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
Published: 2023-01-24 (Crawled : 14:20) - biospace.com/
DYAI 4 | $1.52 2.01% 1.97% 3.4K

| -8.59% | O: 5.52% H: 1.74% C: -1.17%
dyai-100 covid-19 candidate antibody vaccine trial response

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
Published: 2023-01-18 (Crawled : 14:20) - biospace.com/
NVAX | $4.15 -0.96% -0.96% 2.4M

| -66.32% | O: 1.53% H: 8.47% C: -1.19%
covid-19 vaccine approved nuvaxovid

Edge Analytics Market Research Report by Component, Type, Business Application, Deployment Model, Vertical, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 14:20) - prnewswire.com
SAPGF | News | $176.433 -19.46% 1.9K

| 83.53% | O: 0.61% H: 2.67% C: 0.11%
SAP | News | $188.07 0.03% 0.0% 1.2M

| 80.81% | O: -0.73% H: 0.47% C: 0.27%
ORCL | News | $115.34 0.22% -0.3% 5.2M

| 42.99% | O: 0.02% H: 0.48% C: 0.42%
MSFT | News 4 | $408.94 0.34% 0.33% 14M

| 71.11% | O: -0.87% H: 1.17% C: 1.11%
INTC | $34.49 0.61% 0.61% 49M

| 32.0% | O: -0.19% H: 1.04% C: 0.66%
EQIX | $756.59 -0.7% -0.7% 680K

Finance

| 16.31% | O: -0.6% H: 1.14% C: 1.0%
CSCO | News | $48.33 0.02% 0.02% 14M

| 2.11% | O: -0.15% H: 0.51% C: 0.49%
covid-19 analytics research global report impact market

Metal Alloy Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-19 (Crawled : 14:20) - prnewswire.com
MT | News | $25.2 0.04% 0.0% 1M

Non-Energy Minerals

| -1.06% | O: 1.02% H: 0.47% C: -1.44%
AA | $36.08 0.06% -0.11% 5.7M

Non-Energy Minerals

| -15.59% | O: 0.66% H: 0.47% C: -1.58%
covid-19 research global report impact market

Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
Published: 2022-12-14 (Crawled : 14:20) - biospace.com/
DYAI 4 | $1.52 2.01% 1.97% 3.4K

| 26.27% | O: 10.17% H: 3.85% C: -5.38%
dyai-100 covid-19 vaccine study

United States Chemical Industry Report 2022: Statistics, Impact of COVID-19, Market Segments, Industry Globalization, Competition
Published: 2022-11-24 (Crawled : 14:20) - prnewswire.com
HUN | $23.99 -0.17% 0.0% 1.4M

Process Industries

| Email alert Add to watchlist
EMN | $96.36 -0.46% 0.0% 1.1M

Process Industries

| Email alert Add to watchlist
XOM | $121.05 0.02% -0.05% 12M

Energy Minerals

| Email alert Add to watchlist
COP M | $129.28 -0.43% -0.05% 3.8M

Energy Minerals

| Email alert Add to watchlist
covid-19 report impact market

Vaccine Cold Chain Logistics Market Expected to Reach US$ 4.90 Billion by 2030 - Growing Beyond COVID-19 Application
Published: 2022-11-23 (Crawled : 14:20) - prnewswire.com
FDX 4 | $266.07 -2.09% 0.0% 1.7M

Transportation

| 54.69% | O: 0.08% H: 0.61% C: 0.31%
covid-19 growing vaccine application expected market

Natural Gas Storage System Market Research Report by Type, Storage Facility, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-17 (Crawled : 14:20) - prnewswire.com
FTI | $25.72 -0.46% 0.0% 4.7M

Industrial Services

| 109.57% | O: -2.03% H: 2.57% C: 2.57%
ENB | $35.66 0.68% 0.39% 8M

Industrial Services

| -12.39% | O: -1.16% H: 1.1% C: 0.9%
covid-19 research global system report impact market

Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster
Published: 2022-11-08 (Crawled : 14:20) - biospace.com/
NVAX | $4.15 -0.96% -0.96% 2.4M

| -78.44% | O: -3.96% H: 8.79% C: 5.31%
covid-19 vaccine prototype trial

Semiconductor Manufacturing Equipment Market Research Report by Front-End Equipment, Product Type, Dimension, Fab Facility Equipment, Back-End Equipment, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-04 (Crawled : 14:20) - prnewswire.com
ATEYY | $34.305 0.64% 2.1M

n/a

| 166.98% | O: 2.3% H: 0.13% C: 0.13%
TOELF | $214.126 337.05% 470

| -16.3% | O: -0.53% H: 4.73% C: 1.52%
NINOY | $10.27 -3.3% 150K

Manufacturing

| 4.37% | O: 0.0% H: 2.74% C: 0.61%
TOELY | $107.46 0.02% 88K

Manufacturing

| 66.06% | O: -0.43% H: 5.51% C: 3.36%
ONTO 4 | $176.76 0.38% 0.0% 290K

| 155.77% | O: 2.75% H: 2.37% C: 2.01%
VECO | $33.86 0.39% 0.38% 400K

| 94.3% | O: 3.11% H: 0.78% C: 0.56%
NDSN 4 | $260.16 -0.73% -0.74% 160K

| 20.22% | O: 1.55% H: 0.46% C: -0.6%
LRCX | $884.4 -0.34% -0.34% 1.9M

| 125.57% | O: 4.18% H: 2.5% C: 2.36%
ASML | News | $892.13 -1.05% -1.06% 860K

| 104.94% | O: 5.1% H: 1.57% C: 1.39%
AMAT | $196.22 1.54% 1.52% 4.5M

| 123.92% | O: 4.35% H: 1.94% C: 1.83%
covid-19 semiconductor research global report impact market

Satellite Transponder Market Research Report by Bandwidth, Service, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-04 (Crawled : 14:20) - prnewswire.com
NOC | $474.57 -0.02% 0.0% 1.1M

| -9.67% | O: 0.09% H: 0.22% C: -0.61%
LMT | $459.14 -0.2% -0.15% 1M

| -5.1% | O: 0.07% H: 0.28% C: -0.72%
covid-19 satellite research global report impact market

Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds
Published: 2022-10-11 (Crawled : 14:20) - biospace.com/
DGX | News | $137.55 0.62% 0.0% 1.6M

Health Services

| 10.22% | O: 0.15% H: 1.48% C: 0.12%
covid-19 trends breast health year diagnostics cancer study prostate cancer

Omeros Corporation Reports Narsoplimab Treatment Results in Critically Ill COVID-19 Patients in I-SPY COVID Trial
Published: 2022-09-15 (Crawled : 14:20) - biospace.com/
OMER | $3.04 -1.62% -1.64% 250K

| -42.67% | O: -5.57% H: 2.16% C: -21.61%
covid-19 treatment covid trial corporation results

Industrial Cybersecurity Market to Reach $42.96 Billion By 2029 - Market Size, Share, Forecasts & Trends Analysis Report with the Impact of COVID-19 Pandemic by Meticulous Research®
Published: 2022-09-05 (Crawled : 14:20) - prnewswire.com
MSFT | News 4 | $408.94 0.34% 0.33% 14M

| Email alert Add to watchlist
JNPR | $35.36 -1.45% 0.0% 5.3M

| Email alert Add to watchlist
CYBR | News | $244.48 1.82% 1.76% 580K

| Email alert Add to watchlist
ORCL | News | $115.34 0.22% -0.3% 5.2M

| Email alert Add to watchlist
CHKP | News | $161.03 0.14% 0.14% 1M

| Email alert Add to watchlist
INTC | $34.49 0.61% 0.61% 49M

| Email alert Add to watchlist
FTNT M | $65.46 1.02% 1.01% 3.8M

| Email alert Add to watchlist
covid-19 research trends report impact cybersecurity market

Industrial Wastewater Treatment Market Worth $174.9 Billion by 2029 - Market Size, Share, Forecasts & Trends Analysis Report with the Impact of COVID-19 Pandemic by Meticulous Research®
Published: 2022-09-01 (Crawled : 14:20) - prnewswire.com
GFL | $32.86 -1.05% 0.0% 910K

Transportation

| 18.72% | O: 1.57% H: 3.15% C: 2.28%
DD | News | $73.96 0.22% 0.0% 1.5M

Process Industries

| 32.64% | O: -0.74% H: 0.33% C: 0.0%
MMM | $92.02 -1.05% 0.0% 3.8M

| -25.21% | O: -0.04% H: 1.68% C: 1.07%
covid-19 research treatment trends report impact market

Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
Published: 2022-08-31 (Crawled : 14:20) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480

| 18.32% | O: 0.75% H: 1.98% C: 1.98%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -42.6% | O: 0.35% H: 0.6% C: -1.7%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 14.25% | O: 1.1% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -39.84% | O: 0.63% H: 1.42% C: -2.27%
covid-19 fda vaccine granted authorization

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through 17
Published: 2022-08-26 (Crawled : 14:20) - prnewswire.com
NVAX | $4.15 -0.96% -0.96% 2.4M

| -88.75% | O: -0.03% H: 1.53% C: -5.48%
covid-19 vaccine granted authorization

← Previous
1
2
Next →

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M